stockrow
Monday 9 November 2026
Export LXEO’s income statement to Excel — free account
Lexeo Therapeutics, Inc.
LXEOLexeo Therapeutics, Inc.’s revenue for fiscal 2022 (year ended December 2022) was $654,000.00.
- EPS
- +50.0%
- Free cash flow
- +35.6%
- Total debt
- −83.5%
Quarter to June 2026, against a year earlier
2.89
0.02
−0.69%
Follow LXEO
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
122.76 | 181.77 | 193.04 | 211.70 |
Total current assets |
127.79 | 188.39 | 200.86 | 217.91 | |
Property, Plant, Equpment (Net) |
1.23 | 1.14 | 1.10 | 1.12 | |
Long-Term Investments |
3.39 | 68.19 | 37.90 | 25.86 | |
Long-term assets (Other) |
3.25 | 3.25 | 3.25 | 3.25 | |
Total non-current assets |
16.05 | 80.30 | 49.49 | 36.99 | |
Total Assets |
143.84 | 268.69 | 250.36 | 254.90 | |
Accounts Payable |
4.66 | 4.86 | 3.34 | 4.18 | |
Accrued Expenses |
9.90 | 9.28 | 8.16 | 8.85 | |
Current Part of Capital Lease |
0.57 | 0.52 | 0.53 | 0.49 | |
Total current liabilities |
17.27 | 16.81 | 14.19 | 15.69 | |
Long Term Debt (Total) |
0.45 | 0.33 | 0.20 | 0.10 | |
Total non-current liabilities |
5.74 | 5.21 | 4.67 | 4.15 | |
Total liabilities |
23.01 | 22.02 | 18.86 | 19.84 | |
Additional Paid In Capital |
479.97 | 626.63 | 631.98 | 661.57 | |
Common Stock (Net) |
0.01 | 0.01 | 0.01 | 0.01 | |
Retained Earnings |
(359.21) | (380.13) | (400.33) | (426.20) | |
Treasury Stock |
0.02 | 0.02 | 0.02 | 0.02 | |
Common Equity (Total) |
120.83 | 246.67 | 231.50 | 235.06 | |
Shareholders Equity (Total) |
120.83 | 246.67 | 231.50 | 235.06 | |
Shareholders Equity and Liabilities (Total) |
143.84 | 268.69 | 250.36 | 254.90 | |
Shares (Common) |
54.93 | 73.00 | 74.09 | 78.62 | |
Shareholders Equity (Tangible) |
120.83 | 246.67 | 231.50 | 235.06 | |
Net Debt |
(122.31) | (181.44) | (192.84) | (211.61) | |
Total Debt |
0.45 | 0.33 | 0.20 | 0.10 |
In millions of $ except per-share values · columns are period end dates